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The impact of imaging modality (CT vs MRI) and patient position (supine vs 
prone) on tangential whole breast radiation therapy planning 
Abstract 
Purpose 
The purpose of this study was to evaluate the impact of magnetic resonance imaging (MRI) versus 
computed tomography (CT)-derived planning target volumes (PTVs), in both supine and prone positions, 
for whole breast (WB) radiation therapy. 
Methods and materials 
Four WB radiation therapy plans were generated for 28 patients in which PTVs were generated based on 
CT or MRI data alone in both supine and prone positions. A 6-MV tangential intensity modulated radiation 
therapy technique was used, with plans designated as ideal, acceptable, or noncompliant. Dose metrics 
for PTVs and organs at risk were compared to analyze any differences based on imaging modality (CT vs 
MRI) or patient position (supine vs prone). 
Results 
With respect to imaging modality 2/11 whole breast planning target volume (WB_PTV) dose metrics 
(percentage of PTV receiving 90% and 110% of prescribed dose) displayed statistically significant 
differences; however, these differences did not alter the average plan compliance rank. With respect to 
patient positioning, the odds of having an ideal plan versus a noncompliant plan were higher for the 
supine position compared with the prone position (P = .026). The minimum distance between the seroma 
cavity planning target volume (SC_PTV) and the chest wall was increased with prone positioning (P < 
.001, supine and prone values 1.1 mm and 8.7 mm, respectively). Heart volume was greater in the supine 
position (P = .005). Heart doses were lower in the supine position than prone (P < .01, mean doses 3.4 ± 
1.55 Gy vs 4.4 ± 1.13 Gy for supine vs prone, respectively). Mean lung doses met ideal dose constraints in 
both positions, but were best spared in the prone position. The contralateral breast maximum dose to 1cc 
(D1cc) showed significantly lower doses in the supine position (P < .001, 4.64 Gy vs 9.51 Gy). 
Conclusions 
Planning with PTVs generated from MRI data showed no clinically significant differences from planning 
with PTVs generated from CT with respect to PTV and doses to organs at risk. Prone positioning within 
this study reduced mean lung dose and whole heart volumes but increased mean heart and contralateral 
breast doses compared with supine. 
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Abstract: 
Purpose: To evaluate the impact of MRI vs CT derived planning target volumes (PTVs), in both supine and prone 
positions, for whole breast (WB) radiotherapy. 
Methods and Materials: Four WB radiotherapy plans were generated for 28 patients, where PTVs were generated 
based on CT or MRI data alone in both supine and prone positions. A 6MV tangential IMRT technique was used, with 
plans designated as ideal, acceptable or non-compliant. Dose metrics for PTVs and OARs were compared to analyse 
any differences based on imaging modality (CT vs MRI) or patient position (supine vs prone). 
Results: With respect to imaging modality 2/11 WB_PTV dose metrics (V90% and V110%) displayed statistically 
significant differences, however these differences did not alter the average plan compliance rank. With respect to 
patient positioning, the odds of having an ideal plan vs a non-compliant plan were higher for the supine position 
compared to the prone position (p=0.026). The minimum distance between the seroma cavity (SC)_PTV and the 
chest-wall was increased with prone positioning, (p<0.001, supine and prone values 1.1 mm and 8.7 mm 
respectively). Heart volume was greater in the supine position (p=0.005). Heart doses were lower in the supine 
position than prone (p<0.01, mean doses 3.4 ± 1.55 Gy vs 4.4 ± 1.13 Gy for supine vs prone respectively).  Mean lung 
doses met ideal dose constraints in both positions, however best spared in the prone position. The contra-lateral 
breast D1cc showed significantly lower doses in the supine position, (p<0.001, 4.64 Gy vs 9.51 Gy).   
Conclusions: Planning with PTVs generated from MRI data showed no clinically significant differences to planning 
with PTVs generated from CT with respect to PTV and OAR doses. Prone positioning within this study reduced mean 
lung dose and whole heart volumes but increased mean heart and contra-lateral breast doses, compared to supine. 
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Introduction: 
Radiotherapy is an integral component of breast conserving therapy, which has been shown to have equivalent 
survival compared to mastectomy [1, 2]. Long term side effects after radiotherapy for breast cancer, include cardiac 
toxicities [3], radiation fibrosis and second primary cancers [4, 5]. With increasing survivorship, exploration of 
potential changes in practice that could reduce secondary effects is important. 
 
Routinely, computed tomography (CT) is used to delineate target volumes for radiotherapy  [6]. The European 
Society for Radiotherapy and Oncology (ESTRO) consensus guidelines on target delineation for whole breast (WB) 
radiotherapy state the target should include all glandular breast tissue [7], however, the extent of glandular breast 
tissue is not clear on CT scans [8]. Magnetic resonance imaging (MRI) has been shown to better identify breast 
tumours and allow greater distinction between glandular breast tissue and adipose tissue when compared with CT 
[6, 9]. Traditionally, breast MRI is performed with the patient lying in a prone position whilst breast radiotherapy is 
delivered most commonly in the supine position. Previous work demonstrated comparable imaging quality with 
supine versus prone positioning for breast radiotherapy target delineation purposes [10]. The use of the prone 
position for breast radiotherapy is increasing with reported improvements in organ at risk (OAR) doses and target 
dose coverage [11, 12].  
 
Several groups have examined differences in supine and prone positioning for WB radiotherapy [13-24], however 
few groups have examined the impact of imaging modality on breast radiotherapy planning. Mast et al observed that 
the mean volume of delineated glandular breast tissue was significantly larger on CT compared to that volumed on 
co-registered CT- MRI breast radiotherapy planning images acquired with the patient  in the supine position [25]. 
Previous work from our group, incorporating all four elements (CT vs MRI imaging modality and supine vs prone 
patient positioning)  found that WB clinical target volume (CTV) was larger when patients were positioned prone 
than supine, and that seroma cavity (SC) volumes were smaller on MRI than CT [26].  
 
To our knowledge no planning study has been conducted to evaluate the dosimetric implications of imaging 
modality and patient position on target and OAR doses in WB radiotherapy plans. Specifically, our aims were to 
evaluate the impact of differences between MRI and CT derived target volumes, in both supine and prone positions, 
on target and OAR doses for WB radiotherapy. 
 
Methods and Materials: 
Following ethics approval, 33 breast radiotherapy patients were scanned, with both CT and MRI in both supine and 
prone positions. A breakdown of cohort characteristics is presented in table 1. The patients’ actual treatments were 
planned on the supine CT scans as per departmental protocol. The remaining images were used for the planning 
study only. The imaging protocols, image registration and clinical target volume (CTV) contour delineation  
methodology for this planning study has been described previously [26]. Eleven qualified specialists (no trainees; 9 
Radiation Oncologists and 2 Radiologists) from 4 different institutions, contoured WB_CTV and SC_CTV, on all data-
sets  for all patients. No clinical information including pre-operative imaging was supplied to the observers, so that 
contouring observations were based on image data alone. Supine and prone MRI image sets were rigidly registered 
to the corresponding CT scans as described previously [26], based on image data where all contoured structures 
were turned off.  The image fusion was visually confirmed in three planes (axial, sagittal, and coronal), by an 
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experienced radiation therapist.  Some random and all difficult fusions were checked by another experienced 
radiation therapist. 
 
 
Determination of CTVs and PTVs: 
Gold standard CTVs for each  image set were generated using the Simultaneous Truth And Performance Level 
Estimation (STAPLE) algorithm [27], with all observers weighted equally. The WB_CTV STAPLE was generated from all 
11 observers. As no clinical information was provided to observers, there were some cases where the SC was 
incorrectly contoured in different locations across the different observers and imaging modalities (for example, an 
axillary seroma may have been mistaken for a tumour bed seroma in occasional volumes).  To ensure SC_CTV STAPLE 
volumes were clinically relevant for this planning study, they were generated from a variable number of observer 
contours.  The qualitative process to determine which observer contours were utilised in the creation of the SC_CTV 
STAPLE volume is described in appendix 1. There was one patient case in this study where there was no SC_CTV 
staple volume determined. The methodology of determining the planning target volumes (PTVs) is described in 
appendix 2.  
 
Organs At Risk: 
Delineated OARs included the ipsi-lateral and contra-lateral lung, the heart and the contra-lateral breast. Auto-
threshold tools were used to delineate the lung volumes. The heart was contoured to conform to heart atlas 
guidelines [28]. The contra-lateral breast was defined by a radiation therapist, based on visible breast tissue between 
the lateral aspect of the sternum and the latissimus-dorsi muscle postero-laterally, the chest-wall posteriorly and the 
patient contour anteriorly. All OARs were checked by a second radiation therapist.  MRI information was not 
considered in OAR definitions, all OARs were delineated on CT data.   
 
Planning Technique:  
After image registration, the MRI STAPLE CTVs were imported onto the respective CT data-set for planning. Plans 
were generated for the MRI PTV STAPLE in the supine position, the CT PTV STAPLE in the supine position, the MRI 
PTV STAPLE in the prone position and the CT PTV STAPLE in the prone position, for all participants.  All planning 
calculations were performed on the CT data-sets, using the OARs derived from the CT data-sets using a 0.253 dose 
grid and the adaptive convolve algorithm in Pinnacle3 version 9.10 (Philips, Netherlands). A 6MV tangential IMRT 
technique was used where plans were limited to: a maximum of 8 segments, a minimum segment area of 9 cm2, and 
a minimum monitor unit limit of 6. This approach was chosen as it represents current clinical practice [29-31], and 
allowed automation of planning steps with the use of scripts.  In all cases the medial tangential gantry angle 
selection was based on optimal PTV coverage whilst minimising dose to the surrounding OARs. For supine plans this 
process was automated through utilisation of a point dose optimiser tool in the treatment planning system; however 
the option to adjust manually was available for the planner. For prone plans all gantry angles were determined 
manually. A prescription of 50 Gy in 25 fractions was used for all cases. After the script was finished, if required, the 
planner spent a further 10 mins adjusting weightings and optimisation parameters with the aim of meeting the dose 
compliance criteria shown in table 2. This dose compliance criteria used for the target volumes and OARs were based 
on the RTOG 1005 protocol [32], with a tighter criterion for the acceptable WB_PTV dose designation (V45Gy=95% 
our study vs V45Gy = 90% RTOG 1005) was used based on current clinical practice of the authors. Plans were 
designated as ideal, acceptable or non-compliant based on the criteria.  Boost doses to the SC_PTV were not 
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considered in this study, however the dose received to the SC from the WB plan was an important part of the plan 
compliance as outlined in table 2.  
 
Analysis: 
In addition to the metrics recorded to assess plan compliance, the following were determined for reporting 
purposes:  
i. Manual measures of SC_PTV distance to the chest-wall (measured using the treatment planning system 
software), 
ii. Patient and tumour characteristics (documented from treatment records), 
iii. Homogeneity Index (HI) (determined as HI = (D2% - D98%)/(D50%) where an optimal value = 0 [33], ) 
  
Chi square tests were used to test for differences in plan ranks between imaging modality (CT vs MRI) and patient 
position (supine vs prone).  Paired t-tests were used to analyse any differences in OAR volumes with imaging 
modality.  Multilevel models were used to determine whether there were differences in target volumes and the dose 
metrics between imaging modality and patient position. Normality of residuals was assessed with histograms and 
quantile-quantile plots. Cook’s distance was used to identify patients with relatively large influence on the results. 
Based on these diagnostics, transformations on the outcome variable and sensitivity analyses were performed. 
Statistical analysis was conducted using SAS version 9.4. To improve normality of residuals from the multilevel 
models, inverse hyperbolic sine transformations were performed for WB_PTV_V107%, Ipsi-lateral Lung_V20Gy, Ipsi-
lateral Lung_V10Gy, Ipsi-lateral Lung_V5Gy, Heart_V25Gy, Heart_V20Gy, Heart_V10Gy, Heart_mean dose (Gy), 
Contra-lateral Breast_V1.86Gy, Contra-lateral Breast_D1cc (Gy) due to right skewness of the outcome, to reduce the 
potential bias of the results. 
 
Results: 
Thirty-three patients receiving breast radiotherapy were recruited [26]. From this group, five patients were excluded 
from the planning study due to inadequate alignment (on either the prone CT or prone MRI scan) of the patients 
sternum on the prone breast board with respect to the hole for the ipsilateral breast to fall through. This problem 
has been encountered and described elsewhere [11].  
Target and OAR Volume Analysis: 
There was no volumetric difference with image modality between WB_PTV, SC_PTV, or the minimum distance 
between the SC_PTV and the chest-wall. With respect to patient positioning, there was a significant difference in the 
minimum distance between the SC_PTV and the chest-wall (p < 0.001), with supine and prone values 1.1 mm and 8.7 
mm respectively (Table 3). 
 
A paired t test analysis showed significant differences in volume between all supine and prone image sets 
(irrespective of laterality of disease) for the heart (mean supine heart volume = 475.2 cc, mean prone volume = 
440.5 cc, p=0.005). The volumes of other OARs showed no statistically significant differences between supine and 
prone positioning (Table 3). 
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Plan ranking (ideal/acceptable/non-compliant) 
Chi Square tests showed significant differences across the plan ranks for patient positioning (p<0.001). Specifically, 
the odds of having an ideal plan vs a non-compliant plan was higher for the supine position compared to the prone 
position (p = 0.026) (Figure 1). There were no significant differences with imaging modality.  There were 19/112 non-
compliant plans in total. In 2/28 patient cases non-compliant plans occurred in all 4 image sets, one left sided case 
and one right sided case.  For the left sided case, all 4 plans failed to meet heart dose compliance criteria. The right 
sided case had a medial SC_PTV and WB_PTV which extended close to midline, and all 4 plans failed to meet 
minimum SC_PTV dose criteria as well as contra-lateral breast dose constraints.  The remaining 11 non-compliant 
plans were all prone cases. Details of all non-compliant plans are listed in table 4.  
 
 
Dose metrics: 
Table 5 summarises the comparison of dose metrics. Contra-lateral lung and right-sided heart dose metrics were not 
analysable with multi-level statistical model analysis due to the prevalence of ‘0’ values. With respect to imaging 
modality, WB_PTV_V90% and WB_PTV_ V110% metrics displayed statistically significant differences between 
imaging modalities.  With respect to patient position there were several WB_PTV dose metrics that were statistically 
different and all lung and heart dose metrics showed significant differences. The prone position achieved better 
sparing of lung tissue compared to supine position, with all ipsi-lateral and combined lung doses significantly lower 
for the prone position (all p values <0.001). Conversely, mean heart doses were lower in the supine position than 
prone (p<0.001, mean doses 3.4 ± 1.55 Gy vs 4.4 ± 1.13 Gy for supine vs prone respectively). The contra-lateral 
breast D1cc showed significant differences with doses lower in the supine position, (p<0.001, 4.64 Gy vs 9.15 Gy for 
prone).   
WB_PTV_HI showed statistically better homogeneity for MRI plans than for CT (HI_MRI =0.19±0.08 HI_CT=0.21 ±0.81 
p=0.047). WB_PTV_HI also demonstrated statistically better homogeneity for supine plans than for prone  after an 
outlier was removed (HI_supine = 0.19±0.09 HI_prone=0.22±0.08 p=0.01). SC_PTV_V95% was found to be 
statistically larger with prone position (difference = -0.91%, p < 0.001). SC_PTV_D1cc, displayed a statistically 
significant increase in supine position compared with prone (difference = 0.66Gy, p < 0.001). 
 
 
Discussion: 
This is the first study to analyse target and OAR dose compliance differences due to imaging modality (CT vs MRI) for 
target volume determination, in both supine and prone positions, although several groups have examined 
differences in supine and prone positioning for WB radiotherapy (Table 6) [13-26]. 
 
A requirement for greater margins when determining PTVs for prone position (compared to supine) for 
reproducibility issues has been demonstrated [35, 36]. In this study the PTV expansion margin were kept the same to 
allow for a comparison based on imaging modality, this may result in an under-estimation of OAR dosimetric 
parameters for the prone results of this study. 
Whilst there were some statistical differences within WB_PTV metrics for both imaging modality and patient 
position, the differences were small and within the same band of plan compliance thus limiting clinical impact. 
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Despite earlier work establishing that the SC_CTVs were smaller on MRI compared to CT [26], there was no 
difference between CT vs MRI SC_PTV size. However, we did not investigate differences in SC location between CT vs 
MRI, and this would need to be taken into account, particularly if boost doses or partial breast (PB) radiotherapy 
scenarios were being considered. Whilst prone positioning did increase the distance between the SC_PTV from the 
chest-wall, when compared to supine, there was no significant difference in dose metrics for the different imaging 
modalities. Other groups have reported no difference in breast dose coverage between supine and prone positions 
[15, 18, 21, 24].  
Our study demonstrates that mean lung doses met ideal dose constraints in both positions, however lung was better 
spared in the prone position. Similar results of prone positioning allowing greater sparing of dose to the lungs have 
been reported by other groups [15, 18-21, 23, 24].  
In this study there was no significant difference in contra-lateral breast dose based on image modality.  However 
with respect to patient positioning, the supine position displayed better contra-lateral breast sparing than prone. For 
the supine position the mean contra-lateral breast D1cc met the “acceptable” plan ranking, compared to “non-
compliant” for the prone position. These results are in contrast to previous groups who have reported no difference 
in doses to the contra-lateral breast with patient position [17, 21]. These conflicting results may be explained by the 
differences between CTV/PTV determination. In our study, field sizes and gantry angles were determined by optimal 
PTV coverage, where the CTV was determined based on imaging alone. In contrast, Griem et al reported no 
difference to contra-lateral breast dose with patient position where the gantry angles were reported to be placed 
according to clinically defined borders as opposed to a contoured volume [17]. Similarly,  Sethi et al  also reported no 
difference to contra-lateral breast dose with patient position, where the WB target was determined  by converting 
the 50% isodose line from clinically placed tangential beams into a structure, then cropping 5 mm from both the field 
edge and skin surface, as opposed to a contouring a target based on breast tissue [21]. Another study compared 
supine free-breathing (FB), supine deep inspiration breath-hold (DIBH) and prone whole breast radiotherapy plans, 
where the CTV was determined on the CT scans with the assistance of radio-opaque markers placed clinically. In line 
with our results, they reported that the volume of the contra-lateral breast receiving >5 Gy was significantly lower 
for the supine position (either DIBH or FB) versus prone [24]. As radiotherapy may increase the incidence of contra-
lateral breast cancer [37], further investigations into differences in contra-lateral breast dose with positioning should 
be considered. 
Analysis of left sided cases showed supine heart dose metrics to be less than prone. There has been controversy with 
respect to best position for reducing heart dose. Some authors report that prone positioning is better at heart dose 
and/or volume sparing than supine [15-17, 20, 23]. Some have reported no significant difference in heart dose 
between prone and supine positions [19, 22]. One group identified a significant benefit of prone positioning on heart 
doses for women where the WB_CTV exceeded 1000 cm3  for WB radiotherapy [18]. They also reported that heart 
tissue moves towards chest-wall in patients positioned prone similarly to our study. Other studies report similar 
findings [13].  Any reported advantages of prone positioning on heart dose for larger patients may be less significant 
with the more recent uptake of breath-hold techniques. The UK HeartSpare study  found that breath hold 
techniques in the supine position was superior to prone positioning for heart sparing[38]. 
 
Results from this study indicate a statistically significant increase in whole heart volume with supine positioning. 
Another group also reported an increase in heart volume with supine positioning when compared to prone [17]. 
Veldeman et al reported no difference in heart volumes between supine and prone-lateral patient positioning [23]. 
We suggest that the anterior surface of the heart may be more difficult to identify and contour in the prone position, 
or perhaps the cavernous nature of the heart sub-structures may collapse when the patient is in a prone position.  
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MRI is increasingly being considered for use in radiotherapy planning due to superior soft tissue contrast when 
compared to CT [39], and the potential for MRI guided radiotherapy [40]. A limitation of  MRI, and hence for this 
study is that patients with a large body habitus are excluded from the cohort  due to restrictions of the bore size. As 
such the results reported here may not be applicable for very large and obese patients (where benefits of prone 
positioning for breast radiotherapy have been reported). Another limitation is the prone positioning board used for 
this study (details are described elsewhere [26])was not designed specifically for radiotherapy as at the time of study 
commencement  no MRI compatible board was available. To determine differences between imaging modalities an 
MRI compatible option was required. We acknowledge that this may limit the applicability of our patient positioning 
results; however as already discussed our positioning results are not dissimilar to other published data.  This study 
investigated differences between radiotherapy breast plans based on target volume delineation differences to 
imaging modality used, this knowledge will support understanding with the advance towards MRI only planning and 
the aim of reducing radiation dose to patients. Previous studies demonstrate that the effect of distortion is minimal 
for breast radiotherapy planning [41]. Previous work from our group, on the same data-set demonstrated that 
supine WB CTVs were smaller in volume than prone WB CTVs [26]. This current study demonstrates that when CTV is 
expanded to PTV and clipped 0.5 cm inside the external skin volume, there is no volume difference in WB_PTV due 
to either imaging modality or patient position. This is likely to be due to a decreased separation across the volume in 
prone position (thus decreasing the volume expanded in the prone position) and the increased surface area of the 
CTV in prone position (due to gravitational pull), thus increasing the effect of clipping the volume to 0.5 cm within 
the skin edge, when compared to corresponding supine volumes. Our planning study demonstrates that there are no 
significant differences in doses to OARs when target doses are determined based on imaging information from MRI 
compared to CT, although we did not investigate differences in SC location between CT vs MRI. Importantly, the 
choice of patient position, does affect OAR doses. We report that whole heart volumes are reduced with prone 
positioning. With prone positioning lung doses are reduced, however heart doses and contra-lateral breast doses are 
increased. 
 
CONCLUSIONS: 
Planning with PTVs generated from MRI data showed no differences compared to planning with PTVs generated 
from conventional CT scans with respect to WB and SC targets and OAR doses, even when seroma cavity volumes 
were not the same. Prone positioning within this study reduced mean lung dose and whole heart volumes but 
increased mean heart and contra-lateral breast doses, compared to supine. Clinicians should consider the 
implications of patient positioning on OAR doses for each individual patient. 
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Figure Legend: 
Figure 1: Comparison of plan compliance ranking (ideal/acceptable/non-compliant). There was a statistically 
significant difference between supine and prone positioning p<0.001 (chi square test). 
 
 
Table Captions: 
Table 1: Patient Characteristics (n= 28)  
Table 2: Plan Compliance Criteria 
Table 3: Comparison of Mean Target and Mean OAR Volumes and SC to chest-wall Distance. 
Table 4: Non-compliant Plan Details 
Table 5: Dose Metrics Averages 
Table 6: Review of breast radiotherapy planning literature 
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Table 1: Patient Characteristics (n= 28) 
 
Abbreviations: UOQ = upper outer quadrant, UIQ = upper inner quadrant, LOQ = lower outer quadrant, LIQ = lower 
inner quadrant, WB = whole breast, PTV = planning target volume, cc = cubic centimetre. 
  
Patient Characteristics 
Side Left 11 
Right 17 
Tumour 
Position 
UOQ 13 
UIQ 7 
LOQ  1 
LIQ 1 
Overlapping lesion of breast 3 
Central portion of breast 2 
Intra-ductal breast 1 
Age mean 58  years 
range 38 – 72 years 
Breast size 
(WB_PTV 
Volume) 
< 500 cc 
501 – 1000 cc 
> 1000 cc 
3 
7 
1 
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Table 2: Plan Compliance Criteria 
Plan Compliance Criteria 
Structure Dose Metric Ideal Acceptable 
WB_PTV  
V95%  >95% N/A 
V90%   N/A >95% 
V107%   <5% N/A 
V110%  N/A <5% 
D 1cc  (Gy) <53.5 Gy <57.5 Gy 
SC_PTV 
V95%  >99% N/A 
V92%  N/A >99% 
D 1cc  (Gy) <55 Gy < 57.5 Gy 
Combined Lung 
Volume 
V20Gy  <10% <10% 
mean dose (Gy) <10 Gy <10 Gy 
Ipsi-lateral Lung 
V20Gy  <15% <20% 
V10Gy <35% <40% 
V5Gy  <50% <50% 
Contra-lateral Lung V5Gy  <10% <15% 
Heart - LEFT SIDED 
CASES 
V25Gy  N/A <5% 
V20Gy  <5% N/a 
V10Gy  <30% <35% 
mean dose (Gy) <4 Gy <5 Gy 
Heart - RIGHT sided 
cases 
V25Gy  N/A <0% 
V20Gy  <0% N/A 
V10Gy  <10% <15% 
mean dose (Gy) <4 Gy <5 Gy 
Contra-lateral 
Breast 
V1.86Gy <5% N/A 
V3.1Gy N/A <5% 
D 1cc  (Gy) <3.1 Gy <5 Gy 
Plans that did not meet either ‘Ideal’ or ‘Acceptable’ criteria were classed as ‘Non-compliant’. 
Abbreviations: WB = whole breast, PTV = planning target volume, SC = seroma cavity, cc = cubic centimetre. 
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Table 1: Comparison of Mean Target and Mean OAR Volumes and SC to chest-wall Distance. 
 Imaging Modality Patient Position 
Anatomical Measure CT MRI p Supine Prone p 
Volume WB _PTV (cc) 808 ± 306 795 ± 303 0.96* 799 ± 298 803 ± 310 0.93* 
Volume SC_PTV (cc) 94 ± 63 75 ± 62 0.11* 80± 57 88± 689 0.53* 
Minimum distance  SC_PTV to chest-wall 
(mm) 
4.9 ± 10.9 4.9 ± 11.1 0.98* 1.1 ± 3.4 8.7 ± 14.2 <0.001* 
Ipsi-lateral Lung Volume (cc)    1300 ± 312 1343 ± 276 0.195† 
Contra - lateral Lung Volume (cc)    1243 ± 310 1274 ± 253 0.368† 
Combined Lung Volume (cc)    2544 ± 558 2618 ± 491 0.220† 
Heart Volume (cc)    475 ± 81 441 ± 67 0.005† 
Contra-lateral Breast Volume (cc)    850 ±342 877 ± 317 0.199† 
* p-value refers to multivariable analysis 
† p-value refers to the paired t test. 
Abbreviations: WB = whole breast, PTV = planning target volume, SC = seroma cavity, cc = cubic centimetre. 
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Table 4: Non-compliant Plan Details: 
ID Laterality Plan ROI dose constraint  not met 
ID3 Left MRI_Prone Heart V25Gy, Heart mean dose,  Contra-lateral breast D1cc * 
ID8 Left CT_Prone Contra-lateral breast D1cc* 
ID9 Left CT_Prone SC_PTV_SCV92% * 
ID14 
 
Right CT_Prone Heart V25Gy 
Right MRI_Prone Heart V25Gy 
ID15 
 
Right CT_Prone Contra-lateral breast D1cc# 
Right MRI_Prone Contra-lateral breast D1cc# 
ID21 
 
Left CT_Supine Heart V25Gy, Heart mean dose 
Left MRI_Supine Heart V25Gy, Heart mean dose 
Left CT_Prone Heart V25Gy 
Left MRI_Prone Heart V25Gy, Heart mean dose 
ID25 
 
Left CT_Prone Contra-lateral breast V 3.1Gy 
Left MRI_Prone Heart V25Gy, Heart mean dose & Contra-lateral breast D1cc 
ID30 
 
Right CT_Supine SC_PTVV92% , Contra-lateral breast V3.1Gy, Contra-lateral breast D1cc 
Right MRI_Supine SC_PTV_SCV92% Contra-lateral breast V3.1Gy, Contra-lateral breast 
D1cc 
Right CT_Prone SC_PTV_SCV92% , Contra-lateral breast D1cc 
Right MRI_Prone Contra-lateral breast D1cc 
ID32 
 
Left CT_Prone Heart V25Gy, Heart mean dose 
Left MRI_Prone Heart V25Gy, Heart mean dose 
*only one of the 2 prone data set plans were non-compliant due to differences in target volumes (the image set with the larger 
PTV had dose criteria that could not be met).  
# The prone PTVs came to midline whereas the supine PTVs were 1.2 cm away from midline 
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Table 5: Dose Metrics Averages 
Structure Metric 
Imaging Modality Comparison Patient Positioning Comparison 
MRI CT 
P-value 
Supine Prone 
P-
value 
mea
n ±SD mean ±SD mean ±SD mean ±SD 
WB_PTV  
Dmean (Gy) 50.16 ±0.54 50.07 ±0.52 0.28 50.23 ±0.35 49.99 ±0.65 <0.001 
V95% (%) 93.56 ±3.20 93.05 ±3.37 0.2 94.81 ±2.50 91.81 ±3.30 <0.001 
V90 (%) 97.57 ±1.50 97.23 ±1.50 0.05 97.86 ±1.57 96.93 ±1.28 <0.001 
V107% (%) 1.47 ±2.13 1.93 ±2.43 0.23 1.49 ±1.73 1.91 ±2.73 0.83 
V110% (%) 0.05 ±0.11 0.18 ±0.41 0.02 0.11 ±0.30 0.11 ±0.32 0.97 
D1cc  (Gy) 54.27 ±0.97 54.45 ±1.08 0.32 54.27 ±0.83 54.45 ±1.20 0.34 
           
           
           
           
           
SC_PTV 
V95% (%) 99.03 ±1.33 98.47 ±2.96 0.51 99.03 ±2.67 98.47 ±1.87 
<0.001
* 
V92% (%) 99.79 ±0.45 99.42 ±2.20 0.44 99.63 ±2.12 99.58 ±0.83 0.34 
D1cc (Gy) 53.07 ±1.18 53.18 ±1.26 0.28 52.77 ±0.95 53.47 ±1.35 
<0.001
* 
           
           
Combined 
Lung 
V20Gy (%) 4.24 ±2.58 4.31 ±2.56 0.8 5.99 ±1.56 2.57 ±2.18 <0.001 
Dmean (Gy) 2.6 ±1.27 2.64 ±1.29 0.74 3.53 ±0.74 1.71 ±1.02 <0.001 
Ipsi-lateral 
Lung 
V20Gy (%) 8.26 ±4.95 8.38 ±4.87 0.81 11.75 ±2.90 4.89 ±3.98 <0.001 
V10Gy (%) 11.55 ±6.48 11.76 ±6.38 0.72 16.46 ±3.40 6.85 ±4.92 <0.001 
V5Gy (%) 16.74 ±8.82 17.08 ±8.66 0.64 23.89 ±4.04 9.94 ±6.12 <0.001 
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Heart (Left 
cases only) 
V25Gy (%) 4.8 ±2.67 4.16 ±2.98 0.15 3.26 ±2.89 5.7 ±2.18 <0.001 
V20Gy (%) 5.07 ±2.88 4.54 ±3.31 0.30 3.85 ±3.15 5.76 ±2.74 0.001 
V10Gy (%) 7.97 ±3.87 7.5 ±4.31 0.43 5.77 ±3.88 9.7 ±3.24 <0.001 
Dmean (Gy) 4.03 ±1.36 3.77 ±1.52 0.32 3.4 ±1.55 4.4 ±1.13 <0.001 
Heart 
(Right 
cases only) 
V25Gy (%) 0.16 0.91 0.00 0.00  0.00 0.00 0.16 0.91  
V20Gy (%) 0.14 0.72 0.00 0.00  0.00 0.00 0.14 0.72  
V10Gy (%) 0.30 1.60 0.01 0.04  0.00 0.00 0.32 1.60  
Dmean (Gy) 0.85 0.34 0.88 0.21  0.85 0.17 0.93 0.35  
Contra-
lateral  
Breast 
V1.86Gy (%) 6.69 ±3.91 7.12 ±4.08 0.41 6.67 ±4.42 7.14 ±3.51 0.10 
V3.1Gy (%) 0.88 ±1.34 0.97 ±1.74 0.67 0.72 ±1.40 1.13 ±1.67 0.06 
D1cc (Gy) 7.04 ±8.39 7.11 ±9.15 0.78 4.64 ±7.19 9.51 ±9.51 <0.001 
*significant p-value only achieved after removing outliers. 
Abbreviations: SD = standard deviation, WB = whole breast, PTV = planning target volume, SC = seroma cavity, cc 
= cubic centimetre, D = dose, V = volume, CI = conformity index, CN = conformity number, Hi = homogeneity 
index. 
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Table 6: Review of breast radiotherapy planning literature 
Study: n=† Image 
Modality  
Patient 
Position 
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Reported results 
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Chino et al 
[13]. 
16 √ √ √ √ N/A heart to chest-wall distance:  diagnostic MRI prone < supine 
planning CT 
DeWyngaert 
et al [14] & 
Lymberis et 
al [20]. 
100 √ X √ √ clinical  Target dose coverage: no difference detected 
Lung dose: prone position superior 
Heart dose: prone position superior in 87% cases 
Fernandez-
Lizarbe et al 
[15]. 
10 √ X √ √ image Target dose coverage: no difference detected 
Lung dose: prone position superior 
Heart dose: V35Gy – prone superior; mean dose - no 
difference detected 
Formenti et 
al [16]. 
400  √ X √ √ mixed Lung volume:  in-field volume prone < supine 
Heart volume: in-field volume prone < supine in 85% cases 
Griem et al 
[17]. 
15 √ X √ √ mixed Target dose coverage: prone superior 
Target volume differences: supine < prone 
Lung dose: prone position superior 
Lung volume:  ipsi-lateral lung - supine > prone; contra-
lateral lung supine < prone 
Heart volume: whole heart volume -  supine > prone; 
irradiated heart volume -  no difference detected 
Contra-lateral breast dose:  no difference detected 
Contra-lateral breast volume:  supine < prone 
Kirby et al 
[18]. 
65 √ X √ √ mixed Target volume differences: no difference detected 
Lung dose: prone position superior 
Heart dose: no difference detected across entire sample, 
however prone better for large breast size 
AC
C
EP
TE
D
 M
AN
U
SC
R
IP
T
ACCEPTED MANUSCRIPT
Krengli et al 
[19] 
41 √ X √ √ image Target dose coverage: supine superior 
Lung Doses: prone position superior 
Heart doses: no difference detected 
Sethi et al 
[21]. 
12 √ X √ √ mixed Target volume differences: no difference detected 
Lung dose: prone position superior 
Heart dose: prone superior (n=4) 
Contra-lateral breast dose: no difference detected 
Varga et al 
[22]. 
61 √ X √ √ image Target dose coverage: supine superior 
Lung dose: prone position superior 
Heart dose: no difference detected 
Contra-lateral breast dose: supine superior initially then no 
difference after positioning technique changed 
Veldeman 
et al [23]. 
18  √ X √ √ image Target dose coverage: no difference detected 
Lung dose: prone position superior 
Lung volume:  ipsi-lateral lung - prone > supine 
Heart dose: prone position superior 
Verhoeven 
et al [24]. 
34 √ X √ √ image Target dose coverage: no difference detected 
Lung dose: prone position superior 
Heart dose: supine DIBH superior to prone 
Contra-lateral breast dose: supine DIBH and supine FB 
superior to prone 
Mast et al 
[25]. 
10 √ √ √ X image Target volume differences: CT volume > CT co-registered 
with MRI 
XXXXX [26]. 33 √ √ √ √ image Target dose coverage: SC volume: MRI < CT 
Target volume differences: Prone WB CTVs  >  supine  
Current 
study: 
28 √ √ √ √ image Target dose coverage: no difference detected 
Target volume differences: no volumetric difference 
detected however distance between SC PTV to 
chest-wall prone > supine 
Lung dose: prone position superior 
Lung volume:  no difference detected 
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Heart dose: supine position superior 
Heart volume: prone < supine 
Contra-lateral breast dose: D1cc supine position superior 
Contra-lateral breast volume: no difference detected 
*Target determination method: defined as either image (where the target was determined by contouring target tissue on an image), clinical 
field (where the target was determined by clinically defined borders) or mixed (where the target was determined by a mix of the previous 
two methodologies). 
† n=sample size 
